Whole-colon investigation vs. flexible sigmoidoscopy for suspected colorectal cancer based on presenting symptoms and signs: a multicentre cohort study.


Journal

British journal of cancer
ISSN: 1532-1827
Titre abrégé: Br J Cancer
Pays: England
ID NLM: 0370635

Informations de publication

Date de publication:
01 2019
Historique:
received: 11 07 2018
accepted: 24 10 2018
revised: 17 10 2018
pubmed: 20 12 2018
medline: 21 9 2019
entrez: 20 12 2018
Statut: ppublish

Résumé

Patients with suspected colorectal cancer (CRC) usually undergo colonoscopy. Flexible sigmoidoscopy (FS) may be preferred if proximal cancer risk is low. We investigated which patients could undergo FS alone. Cohort study of 7375 patients (≥55 years) referred with suspected CRC to 21 English hospitals (2004-2007), followed using hospital records and cancer registries. We calculated yields and number of needed whole-colon examinations (NNE) to diagnose one cancer by symptoms/signs and subsite. We considered narrow (haemoglobin <11 g/dL men; <10 g/dL women) and broad (<13 g/dL men; <12 g/dL women) anaemia definitions and iron-deficiency anaemia (IDA). One hundred and twenty-seven proximal and 429 distal CRCs were diagnosed. A broad anaemia definition identified 80% of proximal cancers; a narrow definition with IDA identified 39%. In patients with broad definition anaemia and/or abdominal mass, proximal cancer yield and NNE were 4.8% (97/2022) and 21. In patients without broad definition anaemia and/or abdominal mass, with rectal bleeding or increased stool frequency (41% of cohort), proximal cancer yield and NNE were 0.4% (13/3031) and 234. Most proximal cancers are accompanied by broad definition anaemia. In patients without broad definition anaemia and/or abdominal mass, with rectal bleeding or increased stool frequency, proximal cancer is rare and FS should suffice.

Sections du résumé

BACKGROUND
Patients with suspected colorectal cancer (CRC) usually undergo colonoscopy. Flexible sigmoidoscopy (FS) may be preferred if proximal cancer risk is low. We investigated which patients could undergo FS alone.
METHODS
Cohort study of 7375 patients (≥55 years) referred with suspected CRC to 21 English hospitals (2004-2007), followed using hospital records and cancer registries. We calculated yields and number of needed whole-colon examinations (NNE) to diagnose one cancer by symptoms/signs and subsite. We considered narrow (haemoglobin <11 g/dL men; <10 g/dL women) and broad (<13 g/dL men; <12 g/dL women) anaemia definitions and iron-deficiency anaemia (IDA).
RESULTS
One hundred and twenty-seven proximal and 429 distal CRCs were diagnosed. A broad anaemia definition identified 80% of proximal cancers; a narrow definition with IDA identified 39%. In patients with broad definition anaemia and/or abdominal mass, proximal cancer yield and NNE were 4.8% (97/2022) and 21. In patients without broad definition anaemia and/or abdominal mass, with rectal bleeding or increased stool frequency (41% of cohort), proximal cancer yield and NNE were 0.4% (13/3031) and 234.
CONCLUSION
Most proximal cancers are accompanied by broad definition anaemia. In patients without broad definition anaemia and/or abdominal mass, with rectal bleeding or increased stool frequency, proximal cancer is rare and FS should suffice.

Identifiants

pubmed: 30563992
doi: 10.1038/s41416-018-0335-z
pii: 10.1038/s41416-018-0335-z
pmc: PMC6342953
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

154-164

Subventions

Organisme : Department of Health
ID : 02/02/01
Pays : United Kingdom

Références

Colorectal Dis. 2010 Feb;12(2):114-8
pubmed: 19207710
Colorectal Dis. 2015 Nov;17(11):980-3
pubmed: 25944142
Br J Surg. 2008 Sep;95(9):1140-6
pubmed: 18623058
Gastrointest Endosc. 2011 Apr;73(4):757-64
pubmed: 21288510
Br J Surg. 2017 Sep;104(10):1393-1404
pubmed: 28634990
Am J Gastroenterol. 2003 Jul;98(7):1634-9
pubmed: 12873591
Colorectal Dis. 2014 May;16(5):O176-81
pubmed: 24299144
Am J Gastroenterol. 2014 Sep;109(9):1461-70
pubmed: 25001258
Colorectal Dis. 2012 Oct;14(10):1197-200
pubmed: 22176613
Am J Gastroenterol. 2002 Feb;97(2):328-33
pubmed: 11866269
ISRN Gastroenterol. 2013 Apr 18;2013:352718
pubmed: 23691336
Clin Endosc. 2016 Jul;49(4):346-9
pubmed: 27484811
Gastroenterology. 1983 Apr;84(4):803-8
pubmed: 6825990
Int J Technol Assess Health Care. 2010 Oct;26(4):362-9
pubmed: 20942988
Lancet. 2013 Apr 6;381(9873):1185-93
pubmed: 23414648
Colorectal Dis. 2010 Oct;12(10):1033-8
pubmed: 19575741
J Gastrointestin Liver Dis. 2014 Jun;23(2):153-9
pubmed: 24949607
Eur J Gastroenterol Hepatol. 2015 Aug;27(8):963-7
pubmed: 26114907
BMJ. 2000 Jun 3;320(7248):1504-8; discussion 1509
pubmed: 10834891
Gut. 2018 Jan;67(1):179-193
pubmed: 29233930
BMJ Open. 2016 May 13;6(5):e011664
pubmed: 27178981
Surgeon. 2011 Apr;9(2):78-82
pubmed: 21342671
Lancet. 2013 Apr 6;381(9873):1194-202
pubmed: 23414650
Endoscopy. 1999 Mar;31(3):227-31
pubmed: 10344426
Health Technol Assess. 2017 Nov;21(66):1-80
pubmed: 29153075

Auteurs

Amanda J Cross (AJ)

Cancer Screening and Prevention Research Group, Department of Surgery and Cancer, Imperial College London, London, UK. amanda.cross@imperial.ac.uk.

Kate Wooldrage (K)

Cancer Screening and Prevention Research Group, Department of Surgery and Cancer, Imperial College London, London, UK.

Emma C Robbins (EC)

Cancer Screening and Prevention Research Group, Department of Surgery and Cancer, Imperial College London, London, UK.

Kevin Pack (K)

Cancer Screening and Prevention Research Group, Department of Surgery and Cancer, Imperial College London, London, UK.

Jeremy P Brown (JP)

Cancer Screening and Prevention Research Group, Department of Surgery and Cancer, Imperial College London, London, UK.

William Hamilton (W)

Institute of Health Research, University of Exeter Medical School, Exeter, UK.

Michael R Thompson (MR)

Department of Colorectal Surgery, Queen Alexandra Hospital, Portsmouth Hospitals NHS Trust, Portsmouth, UK.

Karen G Flashman (KG)

Department of Colorectal Surgery, Queen Alexandra Hospital, Portsmouth Hospitals NHS Trust, Portsmouth, UK.

Steve Halligan (S)

University College London Centre for Medical Imaging, University College London, London, UK.

Siwan Thomas-Gibson (S)

Wolfson Unit for Endoscopy, St Mark's Hospital, London, UK.

Margaret Vance (M)

Wolfson Unit for Endoscopy, St Mark's Hospital, London, UK.

Brian P Saunders (BP)

Wolfson Unit for Endoscopy, St Mark's Hospital, London, UK.

Wendy Atkin (W)

Cancer Screening and Prevention Research Group, Department of Surgery and Cancer, Imperial College London, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH